Cite
MLA Citation
Ignace Vergote et al.. “2022-RA-1548-ESGO Trial in progress update on ENGOT-cx8/GOG-3024/innovaTV 205: addition of a new cohort using first-line tisotumab vedotin + pembrolizumab + carboplatin ± bevacizumab in recurrent/metastatic cervical cancer.” International journal of gynecological cancer, vol. 32, n.d., p. A64. http://access.bl.uk/ark:/81055/vdc_100168339637.0x00004a